Authors
Latest:
Vaccines Show Efficacy, Safety in Preventing Diseases | APhA 2025Kelly Goode, PharmD, BCPS, FAPhA, FCCP, professor in the department of pharmacotherapy and outcomes science at Virginia Commonwealth University, discusses the current landscape of immunization recommendations.
Latest:
OTC Product Roundup: Sleep AidsWhether due to jet lag, stress, major life events, or something else, there are a lot of issues that can cause short-term insomnia. Send patients on their way to a better night’s sleep with these OTC sleep aid recommendations.
Latest:
Oncology Drug Exkivity to be Voluntarily Withdrawn From US MarketExkivity remains available while Takeda works with the FDA on withdrawal timing, and the company said that patients currently taking the therapy will continue to have access after it is withdrawn.
Latest:
Dry Eye Linked to Poor Sleep QualityAll components of sleep quality were reduced significantly in individuals with dry eye disease.
Latest:
Certain Factors May Increase Long COVID Risk in ChildrenChildren who tested positive were more likely to report long COVID symptoms at 90 days than children who tested negative.
Latest:
Now #Trending: Picking and Choosing Items to Stock the Front-EndTapping into nostalgia is one way to guide front-end stock choices.
Latest:
New Drug Review: FDA Approves Lazertinib Combination Therapy for Non–Small Cell Lung CancerStudy results show improvement in progression-free survival at 22 months.
Latest:
Texting Can Boost Revenue and Patient CareEight ways texting can improve patient retention and boost revenue.
Latest:
Sickle Cell Disease Finally Getting Its DueTwo possibly curative gene therapies for the disease, which disproportionately affects Black people, are under consideration by the FDA.
Latest:
The Effects of Psychedelics in Healthy ParticipantsIn a well-blinded study, researchers investigated and directly compared the acute effects of LSD and psilocybin in healthy participants.
Latest:
The Overarching Implications of PBM Reform on the State LevelWith federal reform continuing to stall, Drug Topics caught up with Iowa State Representative Brett Barker, PharmD, to discuss how his state is regulating pharmacy benefit managers.
Latest:
FDA Grants Priority Review to Liso-Cel in Relapsed/Refractory CLL/SLLThe FDA acceptance marks the first step in addressing the unmet need for a lasting treatment option for patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Latest:
Healthcare Provider-Focused Medical Cannabis Research Study Launched by Cannabis Center of Excellence, Medicinal Genomics, and UMass DartmouthThe Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.
Latest:
The Pharmacist’s Role Beyond COVID-19Amid the pandemic, how effectively pharmacists embraced their role as frontline care providers could change the profession forever.
Latest:
Melphalan Flufenamide for Relapsed or Refractory Multiple MyelomaMelphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.
Latest:
Is Your Pharmacy Showing Up Where Today’s Patients Are Searching?From Scripts to Screens: AAP’s Ginny Langbehn Shares Winning Digital Strategies for Independent Pharmacies
Latest:
Q&A: Pharmacists’ Understanding of CKD Therapies, Adverse Effects | ASHP MidyearDenise Kelley, PharmD, BCPS, FASHP, joined Drug Topics to discuss various medications for chronic kidney disease and their common adverse reactions.
Latest:
New Data Shows Cebranopadol’s Potential in Acute Pain ManagementA conversation with Todd Bertoch, MD, chief medical officer for pain research at CenExel and an investigator on the ALLEVIATE-2 trial.
Latest:
Cannabinoid Hyperemesis Syndrome: Diagnosis and ManagementA deep dive for pharmacists into this frequently debilitating disorder
Latest:
The Unique Challenges, Growth in the Business of Health-System PharmacyFrom market pressures to regulatory framework, Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed growth in the business of health-system pharmacy and the challenges it has faced.
Latest:
Best Practices on Discussing Birth Control for AdolescentsThere are numerous methods of contraception available for adolescents.
Latest:
Q&A: Building a Better Future for Community PharmacyJennifer Bacci, PharmD, MPH, discusses ways to improve current issues impacting community pharmacy.
Latest:
The Evolution of PharmacogenomicsPharmacogenomics provides an opportunity for pharmacists to enhance their role in patient care.
Latest:
Symptom Scoring Framework Helps Formalize Definition of Long COVIDFinalizing a definition for postacute sequelae of SARS-CoV-2 infection will lead to high-quality care and treatment for patients suffering from the condition.
Latest:
National Pharmacy Chain Opioid Settlements Poised to Affect Independent PharmaciesStipulations of the settlements include data reporting, annual training, and an independent compliance officer.
Latest:
Understanding What Vaccines Could Mean for Long COVIDResearch suggests that COVID-19 vaccination may serve a therapeutic effect, possibly reducing the risk of developing long COVID when administered to those currently infected.
Latest:
Probiotics for the Prevention of Pediatric Antibiotic-Associated DiarrheaEvidence of the relationship between probiotics and antibiotics is lacking.
Latest:
Empowering Pharmacists with Responsible AIA Patient Care Journey from a Pharmacist Perspective
Latest:
FDA, CDC Increase Availability of RSV Monoclonal Antibody for InfantsThe federal agencies said that they will continue to work closely with manufacturers to maintain the availability of the vaccines through the end of 2023 and early 2024 to meet the demand during the RSV season.
